“…The characteristics of the eligible studies are summarized in Table 1. Ten studies were conducted in India [4, 11, 21, 22, 30, 33-35, 37, 42], four in Turkey [6,31,32,36], four in China [26,38,39,41], three in Iran [12,23,28], two in Taiwan [8,27], one in Spain [24], one in Saudi Arabia [29], one in Thailand [40], and one in Pakistan [25]. Sample sizes in these studies ranged from 15 to 328 patients.…”